← Eichor
Study identifier: NCT07027033 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Nutritional Oleic Acid Modulation of adIpose Cholesterol Metabolism in Patients Living With Obesity

Condition: Obesity · Visceral Adipose Tissue · White Adipose Tissue Inflammation  ·  Sponsor: Nantes University Hospital

PhaseNA
Planned participants40
Who can joinFemale, 18 Years to 60 Years
Healthy volunteersNo

About this study

Disruption of white adipose tissue (WAT) homeostasis during obesity is central to the development of associated cardiometabolic complications. Dietary supplementation with oleic acid in obese patients can limit these complications. Experimental data, obtained in preclinical models, suggest that the beneficial effects of oleic acid may protect the TAB by increasing cholesterol esterification. The NAMICO study aims to test this hypothesis using TAB biopsies collected from obese patients undergoing bariatric surgery who had previously undergone dietary enrichment with either a conventional oil or an oil rich in oleic acid.

This description comes directly from the study's public registry record.

Talk to the study team

Marie De Montrichard, PH  ·  +332 40 08 30 22  ·  marie.dabadie@chu-nantes.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU de NantesNantes, France, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07027033